IP Library Granted Patent US 8,222,188
Granted Patent B2
US 8,222,188 · App. 12/493,851 · Granted Jul 17, 2012

Antibody libraries

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,222,188
App. No.
12/493,851
Granted
Jul 17, 2012
Kind
B2
Abstract

The present invention relates to the production of antibody libraries. In particular, the present invention relates to the use of integrating retroviral vectors to generate libraries comprising a plurality of combinations of antibody light chains and heavy chains. The present invention thus provides improved methods of generating and screening antibody libraries comprising large numbers of unique antibodies.

Claims (1)

1. An isolated population of at least 10 5 cells, containing unique antibody heavy chains and unique antibody light chains, wherein each cell comprises at least one first integrated pseudotyped retroviral vector comprising 5′ and 3′ long terminal repeat sequences, wherein said first pseudotyped retroviral vector comprises a promoter internal to the 5′ and 3′ retroviral long terminal repeats operably linked to an unique antibody light chain flanked by two recombination sites inserted in between said retroviral 5′ and 3′ long terminal repeats, wherein each cell further comprises at least one integrated second pseudotyped retroviral vector comprising 5′ and 3′ long terminal repeat sequences, wherein said second retroviral pseudotyped vector comprises a promoter internal to the 5′ and 3′ retroviral long terminal repeats operable linked to an unique antibody heavy chain flanked by two recombination sites inserted in between said second retroviral 5′ and 3′ long terminal repeats, and wherein each cell expresses a unique antibody comprising said unique heavy chain and said unique light chain encoded by said first and second integrated pseudotyped retroviral vectors.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (049221/0673) Recorded Dec 19, 2024
From: JPMORGAN CHASE BANK, N.A.
To: CATALENT PHARMA SOLUTIONS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; R.P. SCHERER TECHNOLOGIES, LLC; REDWOOD BIOSCIENCE, INC.
Reel/Frame 069751/0100 →
SUPPLEMENTAL SECURITY AGREEMENT Recorded May 20, 2019
From: R.P. SCHERER TECHNOLOGIES, LLC; CATALENT PHARMA SOLUTIONS, LLC; REDWOOD BIOSCIENCE, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 049221/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2010
From: BREMEL, ROBERT D.; EAKLE, KURT; IMBODEN, MICHAEL
To: GALA DESIGN, INC.
Reel/Frame 025075/0862 →
MERGER Recorded Oct 1, 2010
From: GALA DESIGN, INC.
To: CARDINAL HEALTH PTS, LLC
Reel/Frame 025075/0867 →
CHANGE OF NAME Recorded Oct 1, 2010
From: CARDINAL HEALTH PTS, LLC
To: CATALENT PHARMA SOLUTIONS, LLC
Reel/Frame 025076/0524 →